AFAP1 and non-small cell lung carcinoma: Our data indicate that AFAP1-AS1 expression was elevated in patients with NSCLC and that AFAP1-AS1 acts as a competing endogenous RNA for miR-139-5p, which is an important suppressor in several tumors (35–39).